The latest price target for Dolby Laboratories (NYSE:DLB) was reported by Rosenblatt on June 13, 2025. The analyst firm set a price target for $95.00 expecting DLB to rise to within 12 months (a possible 28.34% upside). 13 analyst firms have reported ratings in the last year.

The latest analyst rating for Dolby Laboratories (NYSE:DLB) was provided by Rosenblatt, and Dolby Laboratories maintained their buy rating.

The last upgrade for Dolby Laboratories Inc happened on June 3, 2024 when Barrington Research raised their price target to $100. Barrington Research previously had a market perform for Dolby Laboratories Inc.

The last downgrade for Dolby Laboratories Inc happened on November 18, 2022 when Barrington Research changed their price target from N/A to N/A for Dolby Laboratories Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dolby Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dolby Laboratories was filed on June 13, 2025 so you should expect the next rating to be made available sometime around June 13, 2026.

While ratings are subjective and will change, the latest Dolby Laboratories (DLB) rating was a maintained with a price target of $95.00 to $95.00. The current price Dolby Laboratories (DLB) is trading at is $74.02, which is out of the analyst’s predicted range.